Aransas Pass, TX, November 29, 2010 --(PR.com
)-- “Open your eyes. Cannabis is not a substance that can be strictly categorized as an illicit drug; its medical benefits have become undeniable,” says Dr. Andre Lange, M.D., and board member on the Medicinal Marijuana Advocate Group, formerly titled Medicinal Marijuana Advocates group. The Texas-based not-for-profit organization, which solely promotes cannabis as a medication, has begun devoting its efforts to expand past a regional influence.
“With our executive board recently adopting an M.D., PHD professor possessing former lobbying experience, and legal advisor, I am confident that MMAG is prepared to begin nationally educating the public,” says president and founder Alexander Young.
Young, who will launch the tour in late January, plans to begin with Emerald Triangle, California, the location of Becky Martin, member and legal caregiver. During his stay at Martin’s healing center, Young will be conducting video interviews with willing patients. The aspiration will be to further integrate MMAG into the medicinal cannabis patient community.
“Many medical marijuana supporters exhaust energy and resources to present debates, comparing marijuana to fatal substances, or impart out-dated, ineffective arguments. Our uncharged presentations will minimally contrast cannabis to toxic products; instead, the content will consist of a discussion on how the US pharmaceutical industry has been barred from research, by impairing and confining legal hurdles,” says Young.
The organization, now consisting of professionals knowledgeable on PR and marketing tactics—in addition to an understanding of cannabis’ physiological effects—intends to venture to each non-medicinal cannabis state over the next two years. “Widespread support of medical cannabis research isn’t a dream; it’s an achievable goal,” says Tim DaGiau, PR Director and Colorado patient, who treats chronic, violent epileptic seizures. For further information, contact Tim DaGiau at firstname.lastname@example.org.